HomeAurobindo Pharma LtdAurobindo Pharma Ltd walk-in interview for Production, QA, QC on 19th May...

Aurobindo Pharma Ltd walk-in interview for Production, QA, QC on 19th May 2024

AUROBINDO PHARMA LTD, also known as APL Healthcare Ltd, is an expanding Indian multinational pharmaceutical manufacturing company that achieved revenues exceeding US$2.8 Billion in 2018-19. The company has a strong presence in over 34 countries and exports its products to 155 nations. APL holds the position of the 2nd Largest Generic Company in terms of Rx dispensed in the USA. Additionally, APL is recognized as one of the Top 10 Generic players in various European countries including France, Germany, Portugal, UK, Italy, Czech Republic, Netherlands, and Belgium.

AUROBINDO PHARMA LIMITED – Conducting  Walk-In Interviews. APLHC-Unit VII,  Walk-In Interviews for Multiple Departments on 19th May’ 2024 @ Hyderabad

Join Aurobindo Pharma Ltd for walk-in interviews on 19th May 2024 for Production, QA, QC positions. Take the next step in your career with us!

Department: Production / Quality Assurance / Quality Control
Designation: TA / Sr. TA/ Executive / Sr. Executive
Qualification; ITI / Diploma / B.Sc / B.Pharm / M.Pharm
Experience: 2 to 7 years
Job Location: Unit- VII, Jadcherla

WALK-IN INTERVIEW DETAILS:
Date of interview: 19th May 2024
Time: 09:30 AM 01:00 PM
Venue: Aurobindo Pharma Ltd, Unit -III, Bachupally (Mandal), Hyderabad, Telangana – 500090

Please carry these documents:
Last 3 months pay slips
Last 6 months bank statement
Current CTC break-up sheet
All education documents
Aadhar & Pan Card
Aurobindo Pharma Ltd walk-in interview for Production, QA, QC on 19th May 2024

0/5 (0 Reviews)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading